GlassScriptPhysician profile
Anthony David Peters
NPI 1033117205
$5,552.57
in general payments reported to CMS, 2019-2025
59 companies · $764 in 2025
The $764 reported for 2025 was more than what 81% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $829 · 2020: $804 · 2021: $1,175 · 2022: $903 · 2023: $567 · 2024: $512 · 2025: $764.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,842.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,841.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $781.52 | 2019-2025 | |
| Amgen INC. | $416.89 | 2019-2025 | Otezla, Repatha, Evenity |
| Glaxosmithkline, LLC. | $400.18 | 2019-2023 | Shingrix |
| Lilly USA, LLC | $334.98 | 2019-2025 | Mounjaro, Emgality, Jardiance |
| Novo Nordisk INC | $300.61 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Janssen Pharmaceuticals, INC | $232.18 | 2019-2025 | Spravato |
| Boehringer Ingelheim Pharmaceuticals, INC. | $212.38 | 2019-2023 | Jardiance |
| Pfizer INC. | $207.44 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $173.76 | 2019-2025 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $149.63 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $134.52 | 2021-2025 | Rexulti |
| Astrazeneca Pharmaceuticals LP | $122.50 | 2020-2024 | Flumist Quadrivalent, Airsupra |
| Exact Sciences Corporation | $113.21 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Medtronic, INC. | $107.44 | 2022-2025 | Intellis Adaptivestim, Venaseal |
| Sanofi-Aventis U.S. LLC | $103.22 | 2021-2025 |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $95.18 | 2021-2025 | Gardasil 9, Vaxneuvance, Rotateq |
| Sanofi Pasteur INC. | $94.86 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $88.44 | 2021-2023 | |
| Amarin Pharma, INC. | $88.38 | 2020-2021 | |
| Corcept Therapeutics | $87.56 | 2021-2025 | Korlym |
| Abbott Laboratories | $79.14 | 2024-2025 | Freestyle Libre 3 |
| Novartis Pharmaceuticals Corporation | $71.33 | 2019-2025 | |
| Daiichi Sankyo INC. | $68.88 | 2019-2025 | Injectafer |
| Astellas Pharma US INC | $66.41 | 2019-2020 | |
| Horizon Therapeutics Plc | $64.88 | 2020-2023 | Krystexxa |
| Corium, LLC | $64.58 | 2023 | Azstarys |
| Dexcom, INC. | $55.25 | 2023-2025 | Dexcom G6 Transmitter |
| Alfasigma USA, INC. | $49.80 | 2020 | |
| Gilead Sciences, INC. | $49.72 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $46.19 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $43.27 | 2022 | |
| Xeris Pharmaceuticals, INC. | $41.50 | 2021-2025 | Recorlev |
| Edwards Lifesciences Corporation | $39.90 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Pacira Therapeutics, INC. | $39.61 | 2019-2021 | |
| Verona Pharma, INC. | $37.17 | 2025 | Ohtuvayre |
| Alexion Pharmaceuticals, INC. | $33.87 | 2025 | Strensiq |
| E.R. Squibb & Sons, L.L.C. | $31.08 | 2019-2023 | Eliquis |
| Hologic Sales and Service, LLC | $27.97 | 2021-2022 | |
| Nevro Corp. | $27.72 | 2021 | |
| Alk-Abello, INC | $27.54 | 2024 | Ragwitek, Odactra, Grastek |
| Phathom Pharmaceuticals, INC. | $24.97 | 2025 | Voquezna |
| Grifols USA, LLC | $24.38 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $23.63 | 2019 | |
| Antares Pharma, INC. | $20.50 | 2019 | |
| Eisai INC. | $20.02 | 2021 | |
| Genentech USA, INC. | $19.56 | 2020 | |
| Halozyme INC | $19.38 | 2023 | |
| Ironshore Pharmaceuticals INC. | $19.26 | 2023 | Jornay Pm |
| Ultragenyx Pharmaceutical INC. | $19.23 | 2022 | |
| Kyowa Kirin, INC. | $18.88 | 2025 | |
| Sumitomo Pharma America, INC. | $18.76 | 2025 | Gemtesa |
| Allergan, INC. | $18.48 | 2019 | |
| Upsher-Smith Laboratories LLC | $17.06 | 2020 | |
| Urgo Medical North America, LLC | $16.19 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Amneal Pharmaceuticals LLC | $15.73 | 2021 | |
| Medtronic Vascular, INC. | $14.19 | 2019 | |
| Strongbridge US INC. | $13.13 | 2020 | |
| Linus Health, INC. | $11.13 | 2024 | Core Cognitive Evaluation |
| Quidel Corporation | $7.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Peters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.